Nom du produit:1-(3-methyl-1,4-dioxido-2-quinoxalinyl)-3-phenyl-2-propen-1-one
IUPAC Name:3-methyl-2-[(2E)-3-phenylprop-2-enoyl]quinoxaline-1,4-diium-1,4-bis(olate)
- CAS:81810-66-4
- Formule moléculaire:C18H14N2O3
- Pureté:97%
- Numéro de catalogue:CM141945
- Poids moléculaire:306.32
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:81810-66-4
- Formule moléculaire:C18H14N2O3
- Point de fusion:-
- Code SMILES:CC1=C(C(/C=C/C2=CC=CC=C2)=O)[N+]([O-])=C3C=CC=CC3=[N+]1[O-]
- Densité:
- Numéro de catalogue:CM141945
- Poids moléculaire:306.32
- Point d'ébullition:
- N° Mdl:MFCD09753267
- Stockage:Store at 2-8°C.
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.